罕见病知识库 RareSeen

药物诱导局限性脂肪代谢障碍

Drug-induced localized lipodystrophy

ORPHA:90157疾病

定义 英文原文(暂无中文)

Drug-induced localized lipodystrophy is a rare, acquired, localized lipodystrophy characterized by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.

别名

药物注射后脂肪萎缩

基本事实

发病年龄
各年龄段
患病率
<1 / 1 000 000

临床表型 6

必现 100%1

  • 脂肪萎缩 HP:0100578

极常见 99–80%1

  • 皮下脂肪组织减少 HP:0003758

常见 79–30%1

  • 皮下脂肪缺如 HP:0007485

偶见 29–5%3

  • 红斑 HP:0010783
  • 皮肤色素沉着 HP:0000953
  • 皮肤色素减退 HP:0001010

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)